logo
Share SHARE
FONT-SIZE Plus   Neg

Consolidated Graphics Profit Tops Estimate; Stock Up - Update

Commercial printing service provider Consolidated Graphics Inc. (CGX), Wednesday reported a higher third-quarter profit, helped by increase in digital print revenues and election-related income. As well, both quarterly earnings and revenue came in ahead of Street analysts' estimates.

Moving forward, the company said prospects for the future appear bright. Shares of Consolidated Graphics gained about six percent in morning trade on the New York Stock Exchange.

Houston, Texas-based Consolidated Graphics reported third-quarter net income of $16 million or $1.68 per share, compared with $10.8 million or $1.04 per share last year.

Excluding items, adjusted earnings for the quarter were $16.9 million or $1.75 per share, compared with $12.7 million or$1.22 per share in the prior year.

On average, 3 analysts polled by Thomson Reuters expected earnings of $1.18 per share for the quarter. Analysts' estimates typically exclude special items.

Revenue for the quarter rose 4 percent to $295 million from $284 million in the prior year. Analysts on consensus estimated revenues of $289.45 million for the quarter.

Digital print revenue for the quarter climbed 3.6 percent, even as the company benefited from robust election-related sales.

Adjusted operating margin for the quarter improved to 8.2 percent from 7.3 percent a year ago.

CGX is trading at $38.75, up $2.15 or 5.87%.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT